TuesdayAug 21, 2018 12:32 pm

Medical Cannabis Payment Solutions (REFG) Specializes in Quality Control from Seed to Sale

Providing first and only comprehensive card processing operation in the cannabis industry Diversifying commitment beyond a payment solution and increasing shareholder value from seed to sale Expanding and strengthening advisory board to achieve corporate objectives The expedited growth and demand of legal marijuana operations has made it difficult for dispensaries to manage all aspects of their operations. There are many moving parts that go into remaining compliant with FinCEN and the Cole Memo, maintaining safety in the handling of funds for a traditionally cash only industry and managing customer satisfaction and quality control. Medical Cannabis Payment Solutions (OTC: REFG) is…

Continue Reading

MondayAug 20, 2018 2:14 pm

The Green Organic Dutchman Ltd. (TSX: TGOD) (OTC: TGODF) Prepares to Spin Off Acquisitions Entity with Opportunity for Shareholders

The Green Organic Dutchman is building a cannabis industry presence with focus on premium, craft-grown product Company is building 1.38 million square feet of cultivation facilities in Canada, Jamaica New Acquisitions Corporation will focus on monetizing TGOD’s experience in finding worldwide opportunities Enters LOI with Denmark-based Knud Jepsen, increasing funded capacity to 195,000 kg annually Amid the rush to market cannabis products in increasingly varied ways, medical cannabis research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) is preparing to reward its shareholders and boost its bottom line by spinning off a new corporation that…

Continue Reading

MondayAug 20, 2018 1:11 pm

Cannabis Strategic Ventures, Inc. (NUGS) Expands Footprint in Billion-Dollar Asian Nutraceuticals Market

CBD market projected to grow to $2.1 billion by 2020 Large Asian-American market receptive to traditional Chinese medicine and nutraceuticals Cannabis Strategic Ventures combines brand experience with niche knowledge Cannabis Strategic Ventures, Inc. (OTC: NUGS) is out to take a slice of the billion-dollar Asian Nutraceutical pie. The company recently cut a deal to acquire the Fitamins CBD brand (http://cnw.fm/LC8cm). Under the terms of the agreement, Fitamins will be distributing its vitamin and hemp-derived CBD formulations through a network of more than 600 wholesalers that serve the Asian-American market. Guided by a team that has developed two successful ventures, Cannabis…

Continue Reading

MondayAug 20, 2018 12:01 pm

ChineseInvestors.com, Inc. (CIIX) Eyes CBD Spin Off as ChineseHempOil.com Subsidiary Hosts Seminar for Chinese Wellness Center in Los Angeles

In MoneyTV interview, Warren Wang, CEO of CIIX, says that the plan is to spin off cannabis line next year, adding that the goal is for CIIX shares to grow from $0.50 to $5.00 in three to five years CIIX’s CBD division to include CBD Biotechnology Co. Ltd., Hemp Logic, Inc. and ChineseHempOil.com, Inc. After the spinoff of CBD assets, CIIX will return to its roots in consulting, brand building and education for the Chinese-speaking community in the U.S. and international markets ChineseInvestors.com, Inc. (OTCQB: CIIX) subsidiary ChineseHempOil.com, Inc. is growing the strategic retail placement of its CBD-related products and…

Continue Reading

FridayAug 17, 2018 1:42 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Progress in Revolutionary Alternative to Smoking for Drug Delivery

Smoking-related deaths have reached six million a year worldwide Lexaria’s patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking’s hazards Second round of testing continues to indicate that patented DehydraTECH™ platform provides rapid delivery with high bioavailability As world drug industry regulations undergo revolutionary change and increasingly healthy populations find themselves challenged to meet the cares of old age, Canadian biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is forging a path that establishes it as a pioneer in the field of drug delivery platforms. Lexaria’s mission is to ensure…

Continue Reading

FridayAug 17, 2018 12:05 pm

NUGL Inc. (NUGL) Cannabis Brand Locator, Profile App Set to Sweep North America

Comprehensive, flexible web app technology means superior service that meets the needs of expanding cannabis community and industry Powerful web app based engine offers unique search functionality, profile building and networking capabilities for cannabis cultivators, brands, dispensaries and all associated service-related industries U.S. legal cannabis market projected to reach more than $23 billion in consumer spending by 2022 NUGL app gives consumers easy-to-locate info on all things cannabis, with unbiased reviews connecting users to their favorite brands, locations Serving international markets with no geographic limitations thanks to innovative, first-to-market technology NUGL Inc. (OTC: NUGL), the cannabis industry’s new standard of…

Continue Reading

ThursdayAug 16, 2018 1:47 pm

PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Medicinal Cannabis Division Targets Treatment Option for Anxiety Disorders

Anxiety is implicated in several chronic physical illnesses including heart disease, respiratory disorders and gastrointestinal conditions Scientific evidence in several studies shows that CBD exhibits anti-inflammatory and anti-anxiety properties Newly created medicinal cannabis division will focus on development of cannabinoids as preventative treatment for anxiety disorders Use of PreveCeutical’s proprietary Sol-gel nasal delivery platform for cannabinoid therapy promises ease of use, sustained release, better efficacy Preventative medicine industry represents a $3.8 trillion market Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is tackling a topic that many people hesitate to bring up – anxiety disorders, including…

Continue Reading

TuesdayAug 14, 2018 11:31 am

Earth Science Tech, Inc. (ETST) Pursues Multi-National Development of CBD Formulations, Hemp-Based Superfood and Home Testing Kit

In Canada and Brazil, ETST is lab testing three new cannabidiol formulations, developing two more CBD products and conducting studies on its Hygee device for women In the U.S., it is researching CBD’s impact on breast cancer and immune cells ETST is focused on the development of innovative products to reach its goal of becoming a world leader in the CBD space, with three new CBD formulas being developed under a provisory patent Earth Science Tech, Inc. (OTC: ETST) is testing in Canada and Brazil a diverse mix of cannabidiol (CBD) formulations, including a superfood formula (http://cnw.fm/9tTZ1). It is also conducting…

Continue Reading

MondayAug 13, 2018 12:09 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is Named for its Attention to Preventative Health Care

Private placement of $4.9 million in June 2018 Five R&D programs currently underway Preventative health care market set to reach $200 billion by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is on a mission neatly expressed in its name and in the metaphoric maxim “an ounce of prevention is worth a pound of cure.” Yet, notwithstanding that axiom, medicinal practice and health care have been viewed, for almost a millennium, mainly as “cure,” despite always being administered with a dose of “prevention.” Now, in the 21st century, that auxiliary aspect seems to be gaining the recognition it…

Continue Reading

MondayAug 13, 2018 11:36 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study on TurboCBD Capsules Corroborates Earlier DehydraTECH Test Results

Significant bioavailability results were reported from LXRP’s randomized, double-blind European study that evaluated its proprietary TurboCBD capsules, powered by DehydraTECH Results corroborate and confirm in vitro and in vivo studies of DehydraTECH technology that measured high levels of drug delivery being achieved faster than with matching controls LXRP says that it is pleased that DehydraTECH has, to date, repeatedly proved evidence of success within human studies; technology earlier demonstrated ability to deliver nicotine Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is pleased to report significant bioavailability results from its randomized and double-blind European human clinical study of DehydraTECH™ powered TurboCBD™…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722